PE-453 Serum Carboxy-terminal Propeptide of Type 1 Procollagen(PIP) is a Marker of Target Organ Damage in White Coat Hypertensives(Hypertension, clinical-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

Sang‐Hyun Ihm(The Catholic University of Korea Bucheon St. Mary's Hospital), Kyu-Bo Choi(Catholic University of Korea), Ho‐Joong Youn, Ki‐Bae Seung, Eung Ju Kim(Mahindra and Mahindra Limited (India)), Chul Soo Park(Gyeongsang National University), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Pum Joon Kim(St. Paul's Hospital), Kiyuk Chang(St. Mary's Hospital)
Japanese Circulation Journal-english Edition
March 1, 2007
Cited by 0

Related Papers

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304